You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 09 Oct 2025
Cancer Type:
Gastrointestinal, 
Rectal
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Oct 2025
Regimen
Published Date: 09 Oct 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Oct 2025
Drug

Published Date: 06 Oct 2025

Revision Summary:
Drug Monograph: Updated antidote information
Oct 2025
Drug

Published Date: 29 Sep 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New patient information sheet
Sep 2025
Regimen
Published Date: 29 Sep 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded to full regimen monograph

Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Regimen
Published Date: 26 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, Drug Administration and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Sep 2025
Regimen
Published Date: 26 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, Drug Administration and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025
Drug

Published Date: 26 Sep 2025

Revision Summary:
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Sep 2025

Pages